{"title":"Tumor Microenvironment and Immune Escape","authors":"Soldano Ferrone MD, PhD, Theresa L. Whiteside PhD","doi":"10.1016/j.soc.2007.08.004","DOIUrl":null,"url":null,"abstract":"<div><p><span>This article describes the multiple escape mechanisms used by tumor cells to avoid T-cell–mediated recognition and destruction. The discussion focuses on escape mechanisms that may result from changes at the level of TA-specific cytotoxic T lymphocytes and tumor cells in the </span>tumor microenvironment<span>. Specifically, we discuss the negative impact of regulatory T cells<span> and T-cell apoptosis<span> on the tumor antigen–specific cytotoxic T lymphocyte response. We also discuss changes in the expression of histocompatibility antigens by tumor cells, which may affect tumor cell–immune cell interactions.</span></span></span></p></div>","PeriodicalId":49460,"journal":{"name":"Surgical Oncology Clinics of North America","volume":"16 4","pages":"Pages 755-774"},"PeriodicalIF":2.4000,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.soc.2007.08.004","citationCount":"85","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Oncology Clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1055320707000981","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 85
Abstract
This article describes the multiple escape mechanisms used by tumor cells to avoid T-cell–mediated recognition and destruction. The discussion focuses on escape mechanisms that may result from changes at the level of TA-specific cytotoxic T lymphocytes and tumor cells in the tumor microenvironment. Specifically, we discuss the negative impact of regulatory T cells and T-cell apoptosis on the tumor antigen–specific cytotoxic T lymphocyte response. We also discuss changes in the expression of histocompatibility antigens by tumor cells, which may affect tumor cell–immune cell interactions.
期刊介绍:
Published four times each year—January, April, July, and October—Surgical Oncology Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in surgical oncology, including pancreatic cancer, radiation oncology, breast cancer, colorectal cancer, head and neck cancer, palliative care, gene therapy, sarcomas, cancer screening, treatment of colorectal cancer, biliary tract and primary liver tumors, breast cancer, imaging, and more.